spacer
home > ict > winter 2008 > pharma champion
PUBLICATIONS
International Clinical Trials

Pharma Champion

CDISC and other standards groups have continued to have an influence on the pharmaceutical industry, writes Mark Penniston at Omnicare Clinical Research

CDISC PROGRESS REPORT

Since its founding, the Clinical Data Interchange Standards Consortium (CDISC) has grown to an international standard organisation with user groups established in multiple worldwide locations. It is a major champion in the pharmaceutical industry for its work in developing platformindependent data standards for the electronic acquisition and exchange of clinical trial data and metadata. As with any organisation of multiple members, lively discussion continues between individual members and their volunteers. The agreement generated by these discussions is probably a factor in the reason why the community has been adapting these standards, and the importance in understanding the efficiencies gained from using them.

Eighteen of the top 20 pharmaceutical companies and eight of the top 10 clinical research organisations (CROs) are currently members of CDISC (1). Since 2000, membership has grown over 600 per cent, with membership renewal rates greater than 88 per cent (2). Additionally, many vendors with supportive tool sets have appeared in the market place, stating their support for the elements of these standards. Membership has grown internationally, particularly in both Europe and the Pacific Rim.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Mark Penniston, MS, is Vice President of Global Biometrics and Clinical Writing. With a focus on delivering expert service excellence and quality results, Mark brings over 20 years of industry experience to this business. A strong proponent of standardisation and CDISC, Mark led Omnicare Clinical Research to join CDISC in 2004 for the purpose of harmonising internal processes around these globally-recognised definitions.
spacer
Mark Penniston
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

ERT, a global data and technology company that captures critical endpoint data while minimizing uncertainty and risk in clinical trials, today announced a first-of-its-kind partnership with AliveCor, the leader in AI-based, personal ECG technology. The partnership enables ERT to capture digital cardiac safety data with KardiaMobile 6L, the only FDA-cleared personal ECG for patient-administered 6-lead data collection.
More info >>

White Papers

Pandemic respiratory vaccine clinical trials: a departure from business as usual

ICON plc

Around the world, the “V” words are on everyone’s lips: Virus and Vaccines. In response to the urgent need for a vaccine for COVID-19, researchers are, at time of publication, running 500+ clinical trials (and counting) on a number of antivirals, antibodies and vaccines. Promising possibilities range from novel new drugs/vaccines, repurposing treatments currently indicated for HIV, Ebola and malaria, to monoclonal antibodies and immune serum.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement